Conferences & Brokerage Event: "Medical data valorisation and sustainability"
14 Dec 2018
Companies and researchers with an interest in medical data generated through current and future IMI projects, willing to find new contacts.
via the B2Match website, released early October
+ Registration to the event: 12th November, 2018
+ Profile registration: 6th December, 2018
+ Meetings selection: 13th December, 2018
* Brokerage Event: "Pharma meets Academia"
* Conferences: "Medical data valorisation and sustainability"
Registrations are open to professionals working in healthcare and related fields. In particular, we welcome participation from researchers in academia, biotech and pharma companies, research infrastructures, healthcare providers as well as patients representatives and policy makers.
The registration will be organised with the B2Match platform, it will begin in September and end the 12th of November.
The event will focus on the optimal use of medical data generated through current and future IMI projects. Visitors will have a chance to meet representatives from the pharmaceutical industry, biotech companies, academia and research infrastructures to forge new partnerships.
The conference will include sessions on neurodegeneration, oncology, biomarkers and diagnostics and analyse how the long-term use of data generated in this field can be made secure, sustainable and of the best benefit to the patient. It will also be an opportunity to discuss future priorities of IMI, a European public-private partnership funding health research and innovation with support from Horizon 2020, and network with potential collaboration partners for forthcoming projects.
The event will bring together healthcare professionals from academia, industry, research infrastructures, patient organisations and EU funding experts. Invited speakers will include:
• project coordinators from past and current IMI projects
• local flagship projects from related areas
• IMI officials
• European Federation of Pharmaceutical Industries and Associations (EFPIA) representatives
• national policy makers and other stakeholders
The event is organised within the context of the 10-year anniversary of the Innovative Medicines Initiative.